CMC Biopharmaceuticals moves onwards and upwards  

The Danish biotech firm has outgrown in current premises and is building a new and larger base in Copenhagen

Biotech company CMC Biopharmaceuticals has invested a multimillion sum in building a new domicile in Copenhagen. The 4 storey building contains offices, laboratories and ultra-modern pharmaceutical production facilities. CMC has increased its turnover well in excess of forecast and has rapidly outgrown its current premises in Symbion Science Park.


CMC is a Contract Manufacturing Organisation (CMO) making drugs for large international pharmaceutical companies, including the major Danish pharma concern Lundbeck, and specialises in producing proteins and antibodies at a high level of purity. The company currently employs 65 people, generating a turnover which is undisclosed but clearly growing apace.


Link > CMC Biopharmaceuticals

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×